Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000485687 | SCV000571082 | likely pathogenic | not provided | 2016-08-03 | criteria provided, single submitter | clinical testing | The c.583dupT variant in the NDUFAF5 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.583dupT variant causes a frameshift starting with codon Tyrosine 195, changes this amino acid to a Leucine residue, and creates a premature Stop codon at position 2 of the new reading frame, denoted p.Tyr195LeufsX2. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.583dupT variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The c.583dupT variant is a strong candidate for a pathogenic variant, however the possibility it may be a rare benign variant cannot be excluded. |
Labcorp Genetics |
RCV000485687 | SCV003448275 | pathogenic | not provided | 2023-09-17 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 421779). This variant has not been reported in the literature in individuals affected with NDUFAF5-related conditions. This sequence change creates a premature translational stop signal (p.Tyr195Leufs*2) in the NDUFAF5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NDUFAF5 are known to be pathogenic (PMID: 26275793, 30473481, 32918965). |
Baylor Genetics | RCV003470573 | SCV004192005 | likely pathogenic | Mitochondrial complex 1 deficiency, nuclear type 16 | 2023-09-14 | criteria provided, single submitter | clinical testing |